Alan S Gamis

Summary

Affiliation: Children's Mercy Hospital
Country: USA

Publications

  1. ncbi request reprint Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891
    Alan S Gamis
    Section of Hematology Oncology Blood and Marrow Transplantation, Children s Mercy Hospital and Clinics, 2401 Gillham Rd, Kansas City, MO 64108, USA
    J Clin Oncol 21:3415-22. 2003
  2. doi request reprint Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia
    Alan S Gamis
    Children s Mercy Hospitals and Clinics, Kansas City, MO 64108, USA
    Pediatr Blood Cancer 60:964-71. 2013
  3. doi request reprint Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder
    Alan S Gamis
    Division of Hematology Oncology, Children s Mercy Hospitals and Clinics, Kansas City, MO 64108, USA
    Br J Haematol 159:277-87. 2012
  4. pmc Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
    Alan S Gamis
    Children s Mercy Hospital and Clinics, Kansas City, MO 64108, USA
    Blood 118:6752-9; quiz 6996. 2011
  5. ncbi request reprint Surveys: a tool to provoke thought and identify areas of need
    Alan S Gamis
    Division of Hematology Oncology, Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, MO 64108, USA
    Pediatr Blood Cancer 44:205-6. 2005
  6. ncbi request reprint Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review
    Alan S Gamis
    Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
    Pediatr Blood Cancer 44:13-20. 2005
  7. ncbi request reprint Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
    Alan S Gamis
    Children s Mercy Hospital and Clinics, The Cleveland Clinic Foundation, Kansas City, Missouri, USA
    J Pediatr Hematol Oncol 24:2-5. 2002
  8. pmc Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study
    Cindy K Blair
    University of Minnesota Cancer Center, Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA
    Paediatr Perinat Epidemiol 22:288-95. 2008
  9. ncbi request reprint Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
    Gina Mundschau
    Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637, USA
    Blood 101:4298-300. 2003
  10. ncbi request reprint Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group
    Amy M Linabery
    Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Pediatrics 118:e1499-508. 2006

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891
    Alan S Gamis
    Section of Hematology Oncology Blood and Marrow Transplantation, Children s Mercy Hospital and Clinics, 2401 Gillham Rd, Kansas City, MO 64108, USA
    J Clin Oncol 21:3415-22. 2003
    ..To determine the outcome of children with Down syndrome (DS) and acute myeloid leukemia (AML) receiving standard timing chemotherapy without bone marrow transplantation (BMT), with determination of prognostic factors...
  2. doi request reprint Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia
    Alan S Gamis
    Children s Mercy Hospitals and Clinics, Kansas City, MO 64108, USA
    Pediatr Blood Cancer 60:964-71. 2013
    ..Pediatr Blood Cancer 2013; 60: 964-971. © 2012 Wiley Periodicals, Inc...
  3. doi request reprint Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder
    Alan S Gamis
    Division of Hematology Oncology, Children s Mercy Hospitals and Clinics, Kansas City, MO 64108, USA
    Br J Haematol 159:277-87. 2012
    ....
  4. pmc Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
    Alan S Gamis
    Children s Mercy Hospital and Clinics, Kansas City, MO 64108, USA
    Blood 118:6752-9; quiz 6996. 2011
    ..001). Among all, AML subsequently occurred in 16% at a median of 441 days (range, 118-1085 days). The trial is registered at http://www.clinicaltrials.gov as NCT00003593...
  5. ncbi request reprint Surveys: a tool to provoke thought and identify areas of need
    Alan S Gamis
    Division of Hematology Oncology, Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, MO 64108, USA
    Pediatr Blood Cancer 44:205-6. 2005
  6. ncbi request reprint Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review
    Alan S Gamis
    Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
    Pediatr Blood Cancer 44:13-20. 2005
    ..Future trials should focus on age-stratified approaches that exploit the greater sensitivity of DS AML to cytarabine...
  7. ncbi request reprint Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
    Alan S Gamis
    Children s Mercy Hospital and Clinics, The Cleveland Clinic Foundation, Kansas City, Missouri, USA
    J Pediatr Hematol Oncol 24:2-5. 2002
  8. pmc Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study
    Cindy K Blair
    University of Minnesota Cancer Center, Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA
    Paediatr Perinat Epidemiol 22:288-95. 2008
    ..Future research should include larger sample sizes as well as a full assessment of diet including vitamin supplementation to adequately examine the relation between nutritional status and childhood leukaemia...
  9. ncbi request reprint Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
    Gina Mundschau
    Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637, USA
    Blood 101:4298-300. 2003
    ..These results demonstrate that GATA1 is likely to play a critical role in the etiology of TMD, and mutagenesis of GATA1 represents a very early event in DS myeloid leukemogenesis...
  10. ncbi request reprint Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group
    Amy M Linabery
    Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Pediatrics 118:e1499-508. 2006
    ..We explored the association between medical test irradiation, a postulated leukemogenic agent, and acute leukemia among children with Down syndrome...